Aspire Private Capital, LLC Horizon Therapeutics Public LTD CO Transaction History

Aspire Private Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$98.98 - $115.74 $2,474 - $2,893	-25 Reduced 71.43%	10 $1,000
Q1 2023 May 30, 2023	BUY	$107.32 - $113.5 $1,073 - $1,135	10 Added 40.0%	35 $3,000
Q1 2023 May 03, 2023	BUY	$107.32 - $113.5 $1,073 - $1,135	10 Added 40.0%	35 $3,000
Q4 2022 May 30, 2023	SELL	$62.39 - $113.8 $623 - $1,138	-10 Reduced 28.57%	25 $2,000
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $415,798 - $597,516	-7,057 Reduced 99.65%	25 $2,000

Q2 2022 Aug 01, 2022	BUY	$79.4 - $116.36 $12,545 - $18,384	158 Added 2.28%	7,082 $565,000
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $57,987 - $73,682	671 Added 10.73%	6,924 $728,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $41,690 - $50,721	423 Added 7.26%	6,253 $674,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $16,819 - $20,197	-183 Reduced 3.04%	5,830 $639,000
Q2 2021 Aug 09, 2021	BUY	$86.24 - $95.92 $152,299 - $169,394	1,766 Added 41.58%	6,013 $563,000
Q1 2021 May 26, 2021	BUY	$71.83 - $95.48 $305,062 - $405,503	4,247 New	4,247 $391,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.